3 天前 - … Thus, we hypothesized that the LINC01446-SRPK2 complex affects HCC
proliferation and angiogenesis by affecting the phosphorylation state of SRSF1. To support this …

3 天前 - … , oropharyngeal pain, capillary proliferation, mild bone marrow suppression,
nausea, and vomiting as side effects. Therefore, SOX combined with apatinib mesylate and …

3 天前 - … hindered cell survival and proliferation. … survival rate of 4T1 cells under US irradiation
was only 21.4%. This indicated that Cu 2–x Se@cMOF has a good combined therapeutic …

3 天前 - … Rather, cellular pathways controlling immunological, metabolic and proliferative
signaling … Combination therapies can overcome resistance in specific constellations. Overall, …

4 天前 - … refinement, potential toxicity and combination therapies. This review summarizes the
role … vital for endothelial cell proliferation, migration, survival and new vessel development, …

4 天前 - … proliferation. Recent clinical trials have reported that combined with other small-molecule
targeted therapies, … the feasibility of target–immune combination therapy, there are still …

5 天前 - … the proliferation and migration … proliferation and migration by targeting the NF‑κB/ST6GAL1
signaling axis. The findings of the present study indicated the promising therapeutic …

5 天前 - … proliferation and inhibits cell apoptosis in ovarian cancer … In the present study, the
combined therapy group was … malignant melanoma proliferation by melphalan combined with …

5 天前 - … -1 blockade therapy, and MFAP2+ CAFs increase drug resistance in GC cells. (2)
CAFs inhibit apoptosis and ferroptosis and enhance the proliferation of surviving cancer cells. …

5 天前 - … UBE2S was identified in this signature with the potential to predict the survival of …
-1α-dependent manner, thus promoting the proliferation of HCC cells. Mechanistically, UBE2S …